IL103213A - Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics - Google Patents

Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics

Info

Publication number
IL103213A
IL103213A IL10321392A IL10321392A IL103213A IL 103213 A IL103213 A IL 103213A IL 10321392 A IL10321392 A IL 10321392A IL 10321392 A IL10321392 A IL 10321392A IL 103213 A IL103213 A IL 103213A
Authority
IL
Israel
Prior art keywords
helicobacter pylori
medicaments
gastrointestinal disorders
bismuth citrate
treating gastrointestinal
Prior art date
Application number
IL10321392A
Other languages
English (en)
Other versions
IL103213A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL103213A0 publication Critical patent/IL103213A0/xx
Publication of IL103213A publication Critical patent/IL103213A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10321392A 1991-09-20 1992-09-18 Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics IL103213A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919120131A GB9120131D0 (en) 1991-09-20 1991-09-20 Medicaments

Publications (2)

Publication Number Publication Date
IL103213A0 IL103213A0 (en) 1993-02-21
IL103213A true IL103213A (en) 2000-02-29

Family

ID=10701750

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10321392A IL103213A (en) 1991-09-20 1992-09-18 Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics

Country Status (26)

Country Link
US (3) US5674858A (cs)
EP (1) EP0533281B1 (cs)
JP (1) JPH0692850A (cs)
KR (1) KR100257367B1 (cs)
AT (2) ATE228835T1 (cs)
BE (1) BE1005808A5 (cs)
CA (1) CA2078579A1 (cs)
CH (1) CH685372A5 (cs)
CY (1) CY2012A (cs)
CZ (1) CZ282840B6 (cs)
DE (1) DE69232864T2 (cs)
ES (1) ES2188582T3 (cs)
FR (1) FR2682040B1 (cs)
GB (2) GB9120131D0 (cs)
HK (1) HK78197A (cs)
HU (1) HU211170A9 (cs)
IE (1) IE922673A1 (cs)
IL (1) IL103213A (cs)
IT (1) IT1262993B (cs)
MX (1) MX9205313A (cs)
NO (1) NO301456B1 (cs)
NZ (1) NZ244390A (cs)
PT (1) PT533281E (cs)
RU (1) RU2116071C1 (cs)
SK (1) SK280283B6 (cs)
ZA (1) ZA927157B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005315A1 (en) * 1988-10-31 1990-05-17 Sumitomo Cement Co., Ltd. Antireflection articles, process for their production and coating composition
WO1994028898A1 (en) * 1993-06-15 1994-12-22 Pfizer Inc. H2-antagonists as immune stimulants in bacterial infections of cattle or swine
EP0642797B1 (en) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
TW420610B (en) * 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5795871A (en) * 1994-04-26 1998-08-18 Nobuhiro Narita Pharmaceutical composition for treatment of non-small cell lung cancer
AU4493796A (en) * 1995-01-26 1996-08-14 Nycomed Imaging As Bismuth compounds
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
KR970032861A (ko) * 1995-12-29 1997-07-22 김준웅 헬리코박터 피로리 제거용 약제 투여방법
US5900410A (en) * 1996-08-27 1999-05-04 Hartmann; John F. Monotherapy of peptic ulcers and gastritis
DE19709897A1 (de) * 1997-03-11 1998-09-17 Hoechst Ag Wismutsalze von Antibiotika der Moenomycin-Gruppe, Verfahren zu ihrer Herstellung, ihre Verwendung und solche Salze enthaltende Arzneimittel
US6017950A (en) * 1997-08-05 2000-01-25 Millennium Pharmaceuticals, Inc. Methods for controlling gram negative bacteria in mammals
IT1296980B1 (it) * 1997-12-17 1999-08-03 Istituto Pirri S R L Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple
AU3668000A (en) * 1999-04-29 2000-11-17 Russinsky Limited Compounds
EP1313486A1 (en) * 2000-02-29 2003-05-28 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
RU2207115C1 (ru) * 2001-12-27 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Противомикробное средство тариферид
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
AU2004222436A1 (en) 2003-03-17 2004-09-30 Japan Tobacco Inc. Method for increasing the oral bioavailability of S-(2-(((1- (2-ethylbutyl) cyclohexyl)carbonyl) amino) phenyl)-2-methylpropanethioate
US20060194748A1 (en) * 2005-02-28 2006-08-31 National University Corporation Nagoya University Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same
RU2586289C1 (ru) 2012-09-28 2016-06-10 Сантэн Фармасьютикал Ко., Лтд. Терапевтический или профилактический агент от дисфункции мейбомиевых желез или блокады мейбомиевых желез
US10201518B2 (en) 2016-09-28 2019-02-12 The University Of Hong Kong Bismuth(III) compounds and methods thereof
JP7640451B2 (ja) 2018-08-31 2025-03-05 コリア インスティチュート オブ ジオサイエンス アンド ミネラル リソースズ 非吸収性抗生物質及び粘土鉱物の複合体を含む組成物を対象に経口投与するステップを含む、ヘリコバクター・ピロリの除菌方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB772567A (en) * 1954-05-06 1957-04-17 Siegfried Fischl Preparation of stable, injectable bismuth-containing pharmaceutical compositions and the compositions formed thereby
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー,ソーマス・ユリウス 胃腸障害治療のための改良された方法
CH679582A5 (cs) * 1988-07-18 1992-03-13 Glaxo Group Ltd
FI910088A7 (fi) * 1990-01-09 1991-07-10 Brocades Pharma Bv Oraalinen farmaseuttinen koostumus
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
AU8941891A (en) * 1990-12-04 1992-07-08 Anton Jenni Sprinkler installation for the floors of riding halls, hothouses, etc.
US5176698A (en) * 1991-01-09 1993-01-05 Scimed Life Systems, Inc. Vented dilatation cathether and method for venting
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US6095731A (en) * 1994-08-18 2000-08-01 Minakami; Hiroyuki Wheel fixing apparatus, pallet/truck and wheel fixing method, automatic wheel fixing apparatus and mode interchange

Also Published As

Publication number Publication date
AU2458492A (en) 1993-03-25
GB2259647B (en) 1995-11-29
CZ282840B6 (cs) 1997-10-15
KR930005619A (ko) 1993-04-20
CA2078579A1 (en) 1993-03-21
FR2682040B1 (fr) 1994-10-28
EP0533281A1 (en) 1993-03-24
NO923643L (no) 1993-03-22
CZ287892A3 (en) 1993-12-15
ATE228835T1 (de) 2002-12-15
DE69232864D1 (de) 2003-01-16
HK78197A (en) 1997-06-20
ES2188582T3 (es) 2003-07-01
HU211170A9 (en) 1995-11-28
PT533281E (pt) 2003-04-30
EP0533281B1 (en) 2002-12-04
NO301456B1 (no) 1997-11-03
NO923643D0 (no) 1992-09-18
ATA186692A (de) 1997-09-15
US5629297A (en) 1997-05-13
SK287892A3 (en) 1995-06-07
BE1005808A5 (fr) 1994-02-01
US5668130A (en) 1997-09-16
IE922673A1 (en) 1993-03-24
GB9120131D0 (en) 1991-11-06
ITRM920681A0 (it) 1992-09-18
NZ244390A (en) 1997-06-24
CH685372A5 (fr) 1995-06-30
GB9219749D0 (en) 1992-10-28
SK280283B6 (sk) 1999-11-08
US5674858A (en) 1997-10-07
IL103213A0 (en) 1993-02-21
MX9205313A (es) 1993-04-01
ITRM920681A1 (it) 1994-03-18
GB2259647A (en) 1993-03-24
AU663520B2 (en) 1995-10-12
AT403656B (de) 1998-04-27
IT1262993B (it) 1996-07-23
DE69232864T2 (de) 2003-11-20
CY2012A (en) 1998-02-20
ZA927157B (en) 1993-06-15
FR2682040A1 (fr) 1993-04-09
KR100257367B1 (ko) 2000-05-15
RU2116071C1 (ru) 1998-07-27
JPH0692850A (ja) 1994-04-05

Similar Documents

Publication Publication Date Title
IL103213A (en) Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics
EP0494972A4 (en) Effervescent dosage form and method of administering same
IE862554L (en) Pharmaceutical compositions
ZA895936B (en) Pharmaceutical compositions comprising selected lactobacillus strains
EP0242643A3 (en) Nasal administration of drugs
ATE134134T1 (de) Feste arzneizubereitungen zur oralen verabreichung mit verlängerter magenverweilzeit
ATE101517T1 (de) Pharmazeutische zusammensetzung, enthaltend loratadin, ibuprofen und pseudoephedrin.
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
IL84834A0 (en) Pharmaceutical compositions containing certain n-(1-azabicyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
WO1992018111A3 (en) Pharmaceutical composition for the treatment of gastritis
KR970009583B1 (en) Calcium supplements
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
PT86539A (en) Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
IL85388A0 (en) Pharmaceutical compositions containing oxoquinazoline derivatives for the treatment of hyperuricaemia
IL94621A0 (en) Pharmaceutical compositions containing vitamin a in association with various therapeutically active ingredients
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
IL88658A0 (en) 8,9-annelated beta-carbolines and 3,4-dihydro-beta-carbolines,their preparation and pharmaceutical compositions containing them
NZ221542A (en) (4,2,0) bicyclooctane derivatives and pharmaceutical compositions
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
ATE76295T1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
ITMI913248A1 (it) Composizioni terapeutiche adatte per la somministrazione orale contenenti come principio attivo uno o piu' tioesteri del glutatione e procedimento per la preparazione dei suddetti principi attivi

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees